Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $53.01 | $59.60 | -11.05% | 28.65x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.95 | ||
| LQDA | LIQUIDIA CORP | $59.98 | $18.28 | 228.05% | 249.92x | 18.09x | 18.33x | 49.12x | 1.18x | $41.15M | 0.78% | $108.58M | 1.23 | $5.29B | 98.80 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $294.30 | $94.22 | 212.36% | 67.50x | 39.91x | 9.12x | 36.54x | 1.39x | $641.34M | 1.64% | $1.08B | 8.09 | $40.55B | 43.87 | ||
| CORT | CORCEPT THERAPEUTICS INC | $58.22 | $18.85 | 208.94% | 126.57x | 111.19x | 7.91x | 9.80x | 1.19x | $119.79M | 1.97% | $637.99M | 6.11 | $6.15B | -895.85 | ||
| KRYS | KRYSTAL BIOTECH INC | $293.30 | $95.67 | 206.59% | 37.85x | 36.27x | 20.59x | 6.77x | 1.80x | $237.38M | 2.76% | $1.28B | 43.59 | $8.15B | 38.11 | ||
| ADMA | ADMA BIOLOGICS INC | $8.63 | $10.49 | -17.70% | 12.51x | 8.69x | 4.00x | 5.12x | 0.42x | $107.90M | 5.30% | $390.33M | 1.65 | $2.06B | 9.30 | ||
| OMER | OMEROS CORP | $11.97 | $15.53 | -22.91% | 9.21x | -31.43x | 86.74x | -13.68x | 0.46x | -$94.78M | -11.01% | -$63.33M | -0.88 | $1.18B | 12.99 | ||
| ASND | ASCENDIS PHARMA A | $237.98 | $83.78 | 184.05% | 25.22x | 19.16x | 14.51x | 25.75x | 2.35x | $52.94M | 0.36% | $574.09M | 9.24 | $15.16B | 162.59 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $5.92 | $2.82 | 109.60% | 84.57x | 49.54x | 3.21x | 78.55x | 0.81x | $47.52M | 4.71% | $13.01M | 0.08 | $1.17B | 21.88 | ||
| VCEL | VERICEL CORP | $34.49 | $9.14 | 277.47% | 80.21x | 71.54x | 6.00x | 4.94x | 1.69x | $47.49M | 2.71% | $356.23M | 7.02 | $1.75B | 43.21 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.20 | $16.26 | -37.28% | 4.98x | 21.71x | 4.87x | 2.93x | 0.63x | $56.42M | 9.47% | $205.80M | 3.52 | $508.53M | 3.52 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.73 | $70.52 | -2.54% | 23.22x | 8.30x | 5.38x | 37.12x | 0.42x | $667.65M | 8.22% | $219.64M | 1.86 | $9.98B | 16.01 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $49.81 | $40.84 | 21.98% | 35.58x | 12.54x | 2.96x | 1.55x | 0.50x | $767.06M | 8.00% | $6.21B | 32.27 | $7.99B | 16.55 | ||
| RPRX | ROYALTY PHARMA PLC | $52.41 | $39.89 | 31.40% | 27.44x | 9.83x | 9.38x | 3.04x | 0.59x | $2.34B | 10.23% | $9.94B | 22.75 | $38.55B | 33.13 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $207.78 | $95.70 | 117.12% | 26.30x | 23.06x | 15.05x | 4.18x | 1.29x | $122.22M | 2.96% | $997.32M | 50.16 | $4.50B | 19.96 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $237.45 | $48.75 | 387.06% | 505.21x | 9.20x | 3.31x | 3.29x | 1.72x | $1.30B | 8.83% | $4.53B | 73.22 | $18.46B | 27.34 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $53.34 | $15.90 | 235.54% | 54.43x | 48.35x | 5.41x | 6.78x | 1.67x | $164.23M | 4.02% | $605.69M | 7.92 | $3.92B | 35.19 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.44 | $35.86 | -15.11% | 12.03x | 8.29x | 1.96x | 1.94x | 0.45x | $341.79M | 19.42% | $910.35M | 15.75 | $1.33B | 5.62 | ||
| TECH | BIO-TECHNE CORP | $45.47 | $15.39 | 195.49% | 64.04x | 23.12x | 5.87x | 3.41x | 1.31x | $269.60M | 3.79% | $2.09B | 13.34 | $7.20B | 28.13 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.59 | $5.74 | -54.84% | 9.59x | 3.79x | 2.43x | 2.83x | 0.20x | $7.24M | 4.86% | $52.93M | 0.92 | $96.31M | 6.22 | ||
| TGTX | TG THERAPEUTICS INC | $39.43 | $18.62 | 111.74% | 12.25x | 26.27x | 8.13x | 10.35x | 8.01x | -$14.19M | -0.25% | $583.13M | 4.04 | $6.34B | 42.29 | ||
| EXEL | EXELIXIS INC | $48.67 | $30.85 | 57.78% | 15.60x | 14.77x | 5.29x | 6.32x | 1.14x | $917.69M | 7.30% | $1.94B | 7.49 | $12.18B | 11.53 | ||
| UTHR | UNITED THERAPEUTICS CORP | $566.80 | $247.37 | 129.13% | 19.36x | 19.50x | 7.78x | 4.08x | 2.05x | $1.02B | 4.12% | $5.90B | 135.66 | $22.78B | 13.29 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.67 | $2.46 | 49.21% | 15.29x | 15.51x | 2.25x | 3.55x | 1.03x | $4.11M | 1.39% | $82.33M | 1.03 | $228.32M | 10.75 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.21 | $14.90 | 109.47% | 17.24x | 16.22x | 6.39x | 3.77x | 1.96x | $208.13M | 5.45% | $1.01B | 8.28 | $3.07B | 9.15 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $434.31 | $169.75 | 155.86% | 25.53x | 22.20x | 9.03x | 5.69x | 1.82x | $3.71B | 3.36% | $19.36B | 76.20 | $106.72B | 19.79 | ||
| VCYT | VERACYTE INC | $41.69 | $12.34 | 237.86% | 37.56x | 37.04x | 6.12x | 2.47x | 2.16x | $155.34M | 4.68% | $1.34B | 16.90 | $3.10B | 26.95 | ||
| MDXG | MIMEDX GROUP INC | $3.64 | $1.56 | 133.09% | 17.33x | -50.98x | 1.39x | 2.23x | 2.69x | $69.36M | 12.83% | $242.94M | 1.64 | $399.98M | 7.34 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.90 | $1.74 | 9.10% | 10.00x | 8.75x | 1.99x | 2.28x | 0.86x | $13.00M | 8.58% | $67.23M | 0.84 | $119.86M | 5.37 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $630.30 | $442.91 | 42.31% | 14.81x | 13.33x | 4.39x | 2.10x | 0.97x | $4.11B | 6.27% | $31.42B | 302.15 | $65.82B | 11.46 | ||
| INCY | INCYTE CORP | $95.60 | $66.15 | 44.53% | 13.11x | 12.14x | 3.55x | 3.40x | 1.16x | $1.45B | 7.61% | $5.62B | 28.21 | $15.67B | 8.38 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $16.64 | $4.60 | 261.67% | 27.73x | 4.77x | 0.80x | 1.17x | 3.89x | $109.24M | 6.25% | $1.51B | 14.34 | $2.33B | 28.15 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.